Cited by 1,298Liver Disease Diagnosis and TreatmentAdipokines, Inflammation, and Metabolic DiseasesAlcohol Consumption and Health Effects

The DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.

The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice

Open access

Xu, Aimin, Wang, Yu, Keshaw, Hussila, Xu, Lance Yi, Lam, Karen S.L., Cooper, Garth J.S.·2003·Journal of Clinical Investigation

DOI 10.1172/jci200317797PMC PMC162288

Open this paper in CoChat — free account Open PDF

Abstract

Adiponectin has recently been shown to be a promising candidate for the treatment of obesity-associated metabolic syndromes. Replenishment of recombinant adiponectin in mice can decrease hyperglycemia, reverse insulin resistance, and cause sustained weight loss without affecting food intake. Here we report its potential roles in alcoholic and nonalcoholic fatty liver diseases in mice. Circulating concentrations of adiponectin decreased significantly following chronic consumption of high-fat ethanol-containing food. Delivery of recombinant adiponectin into these mice dramatically alleviated hepatomegaly and steatosis (fatty liver) and also significantly attenuated inflammation and the elevated levels of serum alanine aminotransferase. These therapeutic effects resulted partly from the ability of adiponectin to increase carnitine palmitoyltransferase I activity and enhance hepatic fatty acid oxidation, while it decreased the activities of two key enzymes involved in fatty acid synthesis, including acetyl-CoA carboxylase and fatty acid synthase. Furthermore, adiponectin treatment could suppress the hepatic production of TNF-α and plasma concentrations of this proinflammatory cytokine. Adiponectin was also effective in ameliorating hepatomegaly, steatosis, and alanine aminotransferase abnormality associated with nonalcoholic obese, ob/ob mice. These results demonstrate a novel mechanism of adiponectin action and suggest a potential clinical application of adiponectin and its agonists in the treatment of liver diseases.

Integrity signals

Registry

Crossref · 10.1172/jci200317797

Cites

68 of 68 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Atherosclerosis--an inflammatory disease
Ross, R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901143400207 · Cited by 21,725
The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity
Yamauchi, T., Kamon, J., Waki, H., Terauchi, Y., Kubota, N., Hara, K., Mori, Y., Ide, T., Murakami, K., Tsuboyama-Kasaoka, N., et al. (2001) · Nature Medicine · doi:10.1038/90984 · Cited by 4,915
Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase
Yamauchi, T., Kamon, J., Minokoshi, Y., Ito, Y., Waki, H., Uchida, S., Yamashita, S., Noda, M., Kita, S., Ueki, K., et al. (2002) · Nature Medicine · doi:10.1038/nm788 · Cited by 4,238
Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity.
MATTEONI, C., YOUNOSSI, Z., GRAMLICH, T., BOPARAI, N., LIU, Y., & MCCULLOUGH, A. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70506-8 · Cited by 3,345
Plasma Concentrations of a Novel, Adipose-Specific Protein, Adiponectin, in Type 2 Diabetic Patients
Hotta, K., Funahashi, T., Arita, Y., Takahashi, M., Matsuda, M., Okamoto, Y., Iwahashi, H., Kuriyama, H., Ouchi, N., Maeda, K., et al. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.6.1595 · Cited by 3,133
The adipocyte-secreted protein Acrp30 enhances hepatic insulin action
Berg, A. H., Combs, T. P., Du, X., Brownlee, M., & Scherer, P. E. (2001) · Nature Medicine · doi:10.1038/90992 · Cited by 2,526
AdipoQ Is a Novel Adipose-specific Gene Dysregulated in Obesity
Hu, E., Liang, P., & Spiegelman, B. M. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.18.10697 · Cited by 2,261
Novel Modulator for Endothelial Adhesion Molecules
Ouchi, N., Kihara, S., Arita, Y., Maeda, K., Kuriyama, H., Okamoto, Y., Hotta, K., Nishida, M., Takahashi, M., Nakamura, T., et al. (1999) · Circulation · doi:10.1161/01.cir.100.25.2473 · Cited by 2,158
Diet-induced insulin resistance in mice lacking adiponectin/ACRP30
Maeda, N., Shimomura, I., Kishida, K., Nishizawa, H., Matsuda, M., Nagaretani, H., Furuyama, N., Kondo, H., Takahashi, M., Arita, Y., et al. (2002) · Nature Medicine · doi:10.1038/nm724 · Cited by 2,114
Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice
Fruebis, J., Tsao, T., Javorschi, S., Ebbets-Reed, D., Erickson, M., Yen, F. T., Bihain, B. E., & Lodish, H. F. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.4.2005 · Cited by 2,007

Flagged first, then by citations

Show all 68 references

Research works printed but not linked: 6

10.1073/pnas.041591798 · DOI
Kubota, 2002, J. Biol. Chem., 277, 35863
Wilkes, 1996, Am. J. Physiol., 271, E477
Winder, 1999, Am. J. Physiol., 277, E1
10.1210/jc.84.5.1513 · DOI
Funabiki, 2002, Diabetes., 51(Suppl. 2), 32a

Sorted by citations

Items 301–400 of 998

Adiponectin: A Key Adipokine in Alcoholic Fatty Liver
You, M., & Rogers, C. Q. (2009) · Experimental Biology and Medicine · doi:10.3181/0902-mr-61 · Cited by 113
Adiponectin as a target for the treatment of nonalcoholic steatohepatitis with thiazolidinediones: A systematic review
Pοlyzos, S. A., & Mantzoros, C. S. (2016) · Metabolism · doi:10.1016/j.metabol.2016.05.013 · Cited by 113
Pioglitazone in the treatment of NASH: the role of adiponectin
Gastaldelli, A., Harrison, S. A., Belfort‐Aguiar, R., Hardies, J., Balas, B., Schenker, S., & Cusi, K. J. (2010) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2010.04405.x · Cited by 115
Adaptive failure to high-fat diet characterizes steatohepatitis in Alms1 mutant mice
Arsov, T., Larter, C. Z., Nolan, C. J., Petrovsky, N., Goodnow, C. C., Teoh, N., Yeh, M. M., & Farrell, G. C. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.02.032 · Cited by 118
Adiponectin Prevents Diabetic Premature Senescence of Endothelial Progenitor Cells and Promotes Endothelial Repair by Suppressing the p38 MAP Kinase/p16INK4A Signaling Pathway
Chang, J., Li, Y., Huang, Y., Lam, K. S. L., Hoo, R. L. C., Wong, W. T., Cheng, K. K. Y., Wang, Y., Vanhoutte, P. M., & Xu, A. (2010) · Diabetes · doi:10.2337/db10-0582 · Cited by 113
Self-citation
Adiponectin, a unique adipocyte-derived factor beyond hormones
Maeda, N., Funahashi, T., Matsuzawa, Y., & Shimomura, I. (2019) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2019.10.021 · Cited by 113
Adipose tissue dysfunction and visceral fat are associated with hepatic insulin resistance and severity of NASH even in lean individuals
Saponaro, C., Sabatini, S., Gaggini, M., Carli, F., Rosso, C., Positano, V., Armandi, A., Caviglia, G. P., Faletti, R., Bugianesi, E., et al. (2022) · Liver International · doi:10.1111/liv.15377 · Cited by 116
The Role of Ceramides in Diabetes and Cardiovascular Disease Regulation of Ceramides by Adipokines
Field, B. C., Gordillo, R., & Scherer, P. E. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.569250 · Cited by 110
Adiponectin Ameliorates Dyslipidemia Induced by the Human Immunodeficiency Virus Protease Inhibitor Ritonavir in Mice
Xu, A., Yin, S., Wong, L. S. L., Chan, K. W., & Lam, K. S. L. (2003) · Endocrinology · doi:10.1210/en.2003-1140 · Cited by 112
Self-citation
5-Lipoxygenase Deficiency Reduces Hepatic Inflammation and Tumor Necrosis Factor α–Induced Hepatocyte Damage in Hyperlipidemia-Prone Apoe-Null Mice
Martínez‐Clemente, M., Ferré, N., González‐Périz, A., López‐Parra, M., Horrillo, R., Titos, E., Morán‐Salvador, E., Miquel, R., Arroyo, V., Funk, C. D., et al. (2009) · Hepatology · doi:10.1002/hep.23463 · Cited by 113
Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis
Livingston, S. (2003) · PsycEXTRA Dataset · doi:10.1037/e507242006-002 · Cited by 111
From chronic overnutrition to metaflammation and insulin resistance: adipose tissue and liver contributions
Caputo, T., Gilardi, F., & Desvergne, B. (2017) · FEBS Letters · doi:10.1002/1873-3468.12742 · Cited by 112
Decreased plasma adiponectin concentrations are closely associated with nonalcoholic hepatic steatosis in obese individuals
Targher, G., Bertolini, L., Scala, L., Poli, F., Zenari, L., & Falezza, G. (2004) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2004.02151.x · Cited by 110
Hepatic steatosis and insulin resistance are associated with serum imbalance of adiponectin/tumour necrosis factor‐α in chronic hepatitis C patients
Durante‐Mangoni, E., Zampino, R., Marrone, A., Tripodi, M., Rinaldi, L., Restivo, L., Cioffi, M., Ruggiero, G., & Adinolfi, L. E. (2006) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2006.03114.x · Cited by 111
The Epidemiology and Risk Factors of NASH
McCullough, A. J. (2004) · Wiley eBooks · doi:10.1002/9780470987438.ch3 · Cited by 110
Inflammatory Mediators of Hepatic Steatosis
Hijona, E., Hijona, L., Arenas, J. I., & Bujanda, L. (2010) · Mediators of Inflammation · doi:10.1155/2010/837419 · Cited by 105
Citrus unshiu peel extract ameliorates hyperglycemia and hepatic steatosis by altering inflammation and hepatic glucose- and lipid-regulating enzymes in db/db mice
Park, H.-J., Jung, U. J., Cho, S.-J., Jung, H.-K., Shim, S., & Choi, M. (2012) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2011.12.009 · Cited by 108
Pathways of liver injury in alcoholic liver disease
Tilg, H., Moschen, A. R., & Kaneider, N. C. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2011.05.015 · Cited by 108
Identification of a Cytochrome P4502E1/Bid/C1q-dependent Axis Mediating Inflammation in Adipose Tissue after Chronic Ethanol Feeding to Mice
Sebastian, B. M., Roychowdhury, S., Tang, H., Hillian, A. D., Feldstein, A. E., Stahl, G. L., Takahashi, K., & Nagy, L. E. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.254201 · Cited by 107
AMP-Activated Protein Kinase and Metabolic Control
Viollet, B., & Andréelli, F. (2011) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-17214-4_13 · Cited by 113
Anti-Obesity and Anti-Diabetic Effect of Neoagarooligosaccharides on High-Fat Diet-Induced Obesity in Mice
Hong, S. J., Lee, J.-H., Kim, E. J., Yang, H. J., Park, J.-S., & Hong, S. (2017) · Marine Drugs · doi:10.3390/md15040090 · Cited by 106
Monascus yellow, red and orange pigments from red yeast rice ameliorate lipid metabolic disorders and gut microbiota dysbiosis in Wistar rats fed on a high-fat diet
Zhou, W., Guo, R., Guo, W., Hong, J., Li, L., Ni, L., Sun, J., Liu, B., Rao, P., & Lv, X. (2019) · Food & Function · doi:10.1039/c8fo02192a · Cited by 106
Obesity depresses the anti‐inflammatory HSP 70 pathway, contributing to NAFLD progression
Naso, F. C. D., Porto, R. R., Fillmann, H. S., Maggioni, L., Padoin, A. V., Ramos, R. J., Mottin, C. C., Bittencourt, A., Marroni, N. P., & de Bittencourt, P. I. H. (2014) · Obesity · doi:10.1002/oby.20919 · Cited by 108
Selective Elevation of Adiponectin Production by the Natural Compounds Derived from a Medicinal Herb Alleviates Insulin Resistance and Glucose Intolerance in Obese Mice
Xu, A., Wang, H., Hoo, R. L. C., Sweeney, G., Vanhoutte, P. M., Wang, Y., Wu, D., Chu, W., Qin, G., & Lam, K. S. L. (2008) · Endocrinology · doi:10.1210/en.2008-0999 · Cited by 108
Self-citation
Adiponectin: a biomarker of obesity-induced insulin resistance in adipose tissue and beyond
Lu, J., Huang, K., Chang, L., Huang, Y.-S., Chi, Y., Su, T.-C., Chen, C., & Yang, W. (2008) · Journal of Biomedical Science · doi:10.1007/s11373-008-9261-z · Cited by 104
The role of vitamin D and vitamin D binding protein in chronic liver diseases
Pop, T. L., Sîrbe, C., Benţa, G., Mititelu, A., & Grama, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231810705 · Cited by 105
Pharmaceutical properties of calycosin, the major bioactive isoflavonoid in the dry root extract ofRadix astragali
Gao, J., Liu, Z. J., Chen, T., & Zhao, D. (2014) · Pharmaceutical Biology · doi:10.3109/13880209.2013.879188 · Cited by 106
Hepatic exosome-derived miR-130a-3p attenuates glucose intolerance via suppressing PHLPP2 gene in adipocyte
Wu, J., Dong, T., Chen, T., Sun, J., Luo, J., He, J., Wei, L., Zeng, B., Zhang, H., Li, W., et al. (2019) · Metabolism · doi:10.1016/j.metabol.2019.154006 · Cited by 105
AICAR, an AMPK Activator, Has Protective Effects on Alcohol‐Induced Fatty Liver in Rats
Tomita, K., Tamiya, G., Ando, S., Kitamura, N., Koizumi, H., Kato, S., Horie, Y., Kaneko, T., Azuma, T., Nagata, H., et al. (2005) · Alcoholism Clinical and Experimental Research · doi:10.1097/01.alc.0000191126.11479.69 · Cited by 102
The effective fraction isolated from Radix Astragali alleviates glucose intolerance, insulin resistance and hypertriglyceridemia in db/db diabetic mice through its anti-inflammatory activity
Hoo, R. L. C., Wong, J. Y. L., Qiao, C., Xu, A., Xu, H., & Lam, K. S. (2010) · Nutrition & Metabolism · doi:10.1186/1743-7075-7-67 · Cited by 101
Self-citation
Mechanisms of non-alcoholic steatohepatitis
McClain, C. J., Mokshagundam, S. P., Barve, S. S., Song, Z., Hill, D. B., Chen, T., & Deaciuc, I. V. (2004) · Alcohol · doi:10.1016/j.alcohol.2004.07.007 · Cited by 101
Cellular basis of hepatic fibrosis and its role in inflammation and cancer
Kocabayoglu, P. (2012) · Frontiers in Bioscience-Scholar · doi:10.2741/s368 · Cited by 101
The Peroxisome Proliferator-Activated Receptor γ Agonist Rosiglitazone Ameliorates Murine Lupus by Induction of Adiponectin
Aprahamian, T. R., Bonegio, R. G. B., Richez, C., Yasuda, K., Chiang, L.-K., Sato, K., Walsh, K. X., & Rifkin, I. R. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.182.1.340 · Cited by 101
Serum retinol‐binding protein 4 levels are elevated in non‐alcoholic fatty liver disease
Seo, J. A., Kim, N. H., Park, S. Y., Kim, H. Y., Ryu, O., Lee, K. W., Lee, J., Kim, D. L., Choi, K. M., Baik, S. H., et al. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.03072.x · Cited by 99
Decreased Plasma Adiponectin Concentrations Are Closely Related to Steatosis in Hepatitis C Virus-Infected Patients
Petit, J., Minello, A., Jooste, V., Bour, J., Galland, F., Duvillard, L., Vergès, B. L., Olsson, N., Gambert, P., & Hillon, P. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1266 · Cited by 99
Obesity and alcoholic liver disease
Diehl, A. M. (2004) · Alcohol · doi:10.1016/j.alcohol.2004.07.010 · Cited by 99
Role of inflammation in nonalcoholic steatohepatitis
Choi, S. S., & Diehl, A. M. (2005) · Current Opinion in Gastroenterology · doi:10.1097/01.mog.0000182863.96421.47 · Cited by 100
Dietary Conjugated Linoleic Acid Alleviates Nonalcoholic Fatty Liver Disease in Zucker (fa/fa) Rats
Nagao, K., Inoue, N., Wang, Y., Shirouchi, B., & Yanagita, T. (2005) · Journal of Nutrition · doi:10.1093/jn/135.1.9 · Cited by 99
Self-citation
Review article: hepatic steatosis and insulin resistance
Lonardo, A., Lombardini, S., RICCHI, M., Scaglioni, F., & Loria, P. (2005) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2005.02600.x · Cited by 98
Synthesis and biological activity of novel barbituric and thiobarbituric acid derivatives against non-alcoholic fatty liver disease
Ma, L., Li, S., Zheng, H., Chen, J., Lin, L., Ye, X., Chen, Z., Xu, Q., Chen, T., Yang, J., et al. (2011) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2011.02.033 · Cited by 98
Enhancing hepatic glycolysis reduces obesity: Differential effects on lipogenesis depend on site of glycolytic modulation
Wu, C., Kang, J., Peng, L.-J., Li, H., Khan, S. A., Hillard, C. J., Okar, D. A., & Lange, A. J. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.07.003 · Cited by 100
Pathogenesis of alcoholic liver disease
Sugimoto, K., & Takei, Y. (2016) · Hepatology Research · doi:10.1111/hepr.12736 · Cited by 98
Differential gene expression and lipid metabolism in fatty liver induced by acute ethanol treatment in mice
Yin, H.-Q., Kim, M., Kim, J. H., Kong, G., Kang, K., Kim, H., Yoon, B.-I., Lee, M., & Lee, B. (2007) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2007.06.018 · Cited by 97
Adiponectin and its receptors in patients with chronic hepatitis C
Jonsson, J. R., Moschen, A. R., Hickman, I. J., Richardson, M. M., Kaser, S., Clouston, A. D., Powell, E. E., & Tilg, H. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2005.05.030 · Cited by 97
Mechanisms for the anti‐inflammatory effects of adiponectin in macrophages
Huang, H., Park, P., McMullen, M. R., & Nagy, L. E. (2008) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2007.05284.x · Cited by 96
Potential Role of Leptin, Adiponectin and Three Novel Adipokines—Visfatin, Chemerin and Vaspin—in Chronic Hepatitis
Kukla, M., Mazur, W., Bułdak, R. J., & Żwirska-Korczala, K. (2011) · Molecular Medicine · doi:10.2119/molmed.2010.00105 · Cited by 98
Advances in Alcoholic Liver Disease
Beier, J. I., Arteel, G. E., & McClain, C. J. (2010) · Current Gastroenterology Reports · doi:10.1007/s11894-010-0157-5 · Cited by 98
Chemoprevention of nonalcoholic fatty liver disease by dietary natural compounds
Pan, M., Lai, C., Tsai, M., & Ho, C. (2013) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201300522 · Cited by 95
Adiponectin Signaling Pathways in Liver Diseases
Gamberi, T., Magherini, F., Modesti, A., & Fiaschi, T. (2018) · Biomedicines · doi:10.3390/biomedicines6020052 · Cited by 98
Nonalcoholic fatty liver disease: from pathogenesis to patient care
Perlemuter, G., Bigorgne, A., Cassard, A., & Naveau, S. (2007) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0505 · Cited by 98
Association of pro-inflammatory cytokines, adipokines & oxidative stress with insulin resistance & non-alcoholic fatty liver disease.
Kumar, R. K., Prakash, S., Chhabra, S., Singla, V., Madan, K., Gupta, S. D., Panda, S. K., Khanal, S. P., & Acharya, S. K. (2012) · PubMed Central · Cited by 94
Adiponectin prevents progression of steatohepatitis in mice by regulating oxidative stress and Kupffer cell phenotype polarization
Fukushima, J., Kamada, Y., Matsumoto, H., Yoshida, Y., Ezaki, H., Takemura, T., Saji, Y., Igura, T., Tsutsui, S., Kihara, S., et al. (2009) · Hepatology Research · doi:10.1111/j.1872-034x.2009.00509.x · Cited by 94
Adiponectin: Protection of the endothelium
Lam, K. S. L., & Xu, A. (2005) · Current Diabetes Reports · doi:10.1007/s11892-005-0019-y · Cited by 94
Self-citation
Nonalcoholic fatty liver disease decrease in obese adolescents after multidisciplinary therapy
Tock, L., do Prado, W. L., Caranti, D. A., Cristofalo, D. M. J., Lederman, H. M., Fisberg, M., Siqueira, K. L. O., Stella, S. R. G., Antunes, H. K. M., Cintra, I. P., et al. (2006) · European Journal of Gastroenterology & Hepatology · doi:10.1097/01.meg.0000243872.86949.95 · Cited by 93
Regulation of T Cell-Mediated Hepatic Inflammation by Adiponectin and Leptin
Sennello, J. A., Fayad, R., Morris, A., Eckel, R. H., Asilmaz, E., Montez, J. M., Friedman, J. M., Dinarello, C. A., & Fantuzzi, G. (2005) · Endocrinology · doi:10.1210/en.2004-1572 · Cited by 94
How adiponectin, leptin, and ghrelin orchestrate together and correlate with the severity of nonalcoholic fatty liver disease
Machado, M. V., Coutinho, J., Carepa, F., Costa, A., Proença, H., & Cortez‐Pinto, H. (2012) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0b013e32835609b0 · Cited by 92
Modulation of glycosphingolipid metabolism significantly improves hepatic insulin sensitivity and reverses hepatic steatosis in mice #
Bijl, N., Sokolović, M., Vrins, C. L. J., Langeveld, M., Moerland, P. D., Ottenhoff, R., van Roomen, C. P. A. A., Claessen, N., Boot, R. G., Aten, J., et al. (2009) · Hepatology · doi:10.1002/hep.23175 · Cited by 94
Interactions among bone, liver, and adipose tissue predisposing to diabesity and fatty liver
Musso, G., Paschetta, E., Gambino, R., Cassader, M., & Molinaro, F. (2013) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2013.05.006 · Cited by 98
The pathophysiology of abdominal adipose tissue depots in health and disease
Walker, G. E., Marzullo, P., Ricotti, R., Bona, G., & Prodam, F. (2014) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2014-0023 · Cited by 90
Adiponectin and Heme Oxygenase-1 Suppress TLR4/MyD88-Independent Signaling in Rat Kupffer Cells and in Mice after Chronic Ethanol Exposure
Mandal, P., Roychowdhury, S., Park, P., Pratt, B. T., Roger, T., & Nagy, L. E. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1002060 · Cited by 90
Adiponectin activation of AMPK disrupts leptin‐mediated hepatic fibrosis via suppressors of cytokine signaling (SOCS‐3)
Handy, J. A., Saxena, N. K., Pingping, F., Lin, S., Mells, J. E., Gupta, N. A., & Anania, F. A. (2010) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22634 · Cited by 93
Molecular mechanism of alcoholic fatty liver
Rasineni, K., & Casey, C. A. (2012) · Indian Journal of Pharmacology · doi:10.4103/0253-7613.96297 · Cited by 93
Intrahepatic insulin resistance in a murine model of steatohepatitis: effect of PPARγ agonist pioglitazone
Leclercq, I. A., Lebrun, V. A., Stärkel, P., & Horsmans, Y. (2006) · Laboratory Investigation · doi:10.1038/labinvest.3700489 · Cited by 92
Anti-inflammatory pathways and alcoholic liver disease: Role of an adiponectin/interleukin-10/heme oxygenase-1 pathway
Mandal, P. (2010) · World Journal of Gastroenterology · doi:10.3748/wjg.v16.i11.1330 · Cited by 92
Hepatic PPARs: Their Role in Liver Physiology, Fibrosis and Treatment
Zardi, E. M., Navarini, L., Sambataro, G., Piccinni, P., Sambataro, F., Spina, C., & Dobrina, A. (2013) · Current Medicinal Chemistry · doi:10.2174/09298673113209990136 · Cited by 92
Adiponectin deficiency promotes endothelial activation and profoundly exacerbates sepsis-related mortality
Teoh, H., Quan, A., Bang, K. W. A., Wang, G., Lovren, F., Vu, V. P., Haitsma, J. J., Szmitko, P. E., Al-Omran, M. A., Wang, C., et al. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90384.2008 · Cited by 91
The Relationships of Plasma Adiponectin with a Favorable Lipid Profile, Decreased Inflammation, and Less Ectopic Fat Accumulation Depend on Adiposity
Kantartzis, K., Rittig, K., Balletshofer, B. M., Machann, J., Schick, F., Porubská, K., Fritsche, A., Häring, H., & Stefan, N. (2006) · Clinical Chemistry · doi:10.1373/clinchem.2006.067397 · Cited by 90
PPARδ agonist attenuates alcohol-induced hepatic insulin resistance and improves liver injury and repair
Pang, M., de la Monte, S. M., Longato, L., Tong, M., He, J., Chaudhry, R., Duan, K. I., Ouh, J., & Wands, J. R. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.01.021 · Cited by 90
Changes in Serum Adipokine Levels During Pioglitazone Treatment for Nonalcoholic Steatohepatitis: Relationship to Histological Improvement
Lutchman, G. A., Promrat, K., Kleiner, D. E., Heller, T., Ghany, M. G., Yanovski, J. A., Liang, T. J., & Hoofnagle, J. H. (2006) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2006.05.005 · Cited by 90
Non-alcoholic fatty liver and insulin resistance: a cause–effect relationship?
Bugianesi, E., Zannoni, C., Vanni, E., Marzocchi, R., & Marchesini, G. (2004) · Digestive and Liver Disease · doi:10.1016/j.dld.2003.12.008 · Cited by 91
S‐Adenosylmethionine Attenuates Hepatic Lipid Synthesis in Micropigs Fed Ethanol With a Folate‐Deficient Diet
Esfandiari, F., You, M., Villanueva, J. A., Wong, D. H., French, S. W., & Halsted, C. H. (2007) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2007.00407.x · Cited by 89
Exogenous thioredoxin prevents ethanol-induced oxidative damage and apoptosis in mouse liver #
Cohen, J. I., Roychowdhury, S., DiBello, P. M., Jacobsen, D. W., & Nagy, L. E. (2009) · Hepatology · doi:10.1002/hep.22837 · Cited by 88
Protective roles of adiponectin in obesity-related fatty liver diseases: mechanisms and therapeutic implications
Wang, Y., Zhou, M., Lam, K. S. L., & Xu, A. (2009) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302009000200012 · Cited by 90
Self-citation
Circulating adiponectin reflects severity of liver disease but not insulin sensitivity in liver cirrhosis
Kaser, S., Moschen, A. R., Kaser, A., Ludwiczek, O., Ebenbichler, C. F., Vogel, W., Jaschke, W. R., Patsch, J. R., & Tilg, H. (2005) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2005.01543.x · Cited by 86
Telmisartan attenuates progression of steatohepatitis in mice: role of hepatic macrophage infiltration and effects on adipose tissue
Kudo, H., Yata, Y., Takahara, T., Kawai, K., Nakayama, Y., Kanayama, M., Oya, T., Morita, S., Sasahara, M., Mann, D. A., et al. (2009) · Liver International · doi:10.1111/j.1478-3231.2009.02006.x · Cited by 88
Activation of autophagy by globular adiponectin attenuates ethanol-induced apoptosis in HepG2 cells: Involvement of AMPK/FoxO3A axis
Nepal, S., & Park, P. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2013.05.013 · Cited by 84
Roles of adipose restriction and metabolic factors in progression of steatosis to steatohepatitis in obese, diabetic mice
Larter, C. Z., Yeh, M. M., Rooyen, D. M. V., Teoh, N., Brooling, J. T., Hou, J. Y., Williams, J., Clyne, M., Nolan, C. J., & Farrell, G. C. (2009) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2009.05996.x · Cited by 87
Effects of canagliflozin on weight loss in high-fat diet-induced obese mice
Ji, W., Zhao, M., Wang, M., Yan, W., Liu, Y., Ren, S., Lü, J., Wang, B., & Chen, L. (2017) · PLoS ONE · doi:10.1371/journal.pone.0179960 · Cited by 85
Modulating impacts of quercetin/sitagliptin combination on streptozotocin-induced diabetes mellitus in rats
Eitah, H. E., Maklad, Y. A., Abdelkader, N. F., el Din, A. A. G., Badawi, M., & Kenawy, S. A. (2018) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2018.12.011 · Cited by 85
Hepatic accumulation of Hedgehog-reactive progenitors increases with severity of fatty liver damage in mice
Fleig, S. V., Choi, S. S., Yang, L., Jung, Y., Omenetti, A., VanDongen, H. M. A., Huang, J., Sicklick, J. K., & Diehl, A. M. (2007) · Laboratory Investigation · doi:10.1038/labinvest.3700689 · Cited by 86
Ethanol‐Induced Oxidative Stress via the CYP2E1 Pathway Disrupts Adiponectin Secretion from Adipocytes
Tang, H., Sebastian, B. M., Axhemi, A. A., Chen, X., Hillian, A. D., Jacobsen, D. W., & Nagy, L. E. (2011) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2011.01607.x · Cited by 84
Insulin Sensitivity Is Correlated with Subcutaneous but Not Visceral Body Fat in Overweight and Obese Prepubertal Children
Maffeis, C., Manfredi, R. M., Trombetta, M., Sordelli, S., Storti, M., Benuzzi, T., & Bonadonna, R. C. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2089 · Cited by 84
Metabolic correlates of nonalcoholic fatty liver in women and men
Vega, G. L., Chandalia, M., Szczepaniak, L. S., & Grundy, S. M. (2007) · Hepatology · doi:10.1002/hep.21727 · Cited by 84
Protective role of HO-1 and carbon monoxide in ethanol-induced hepatocyte cell death and liver injury in mice
Bakhautdin, B., Das, D., Mandal, P., Roychowdhury, S., Danner, J., Bush, K., Pollard, K., Kaspar, J. W., Li, W., Salomon, R. G., et al. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.06.007 · Cited by 84
Angiotensin-converting enzyme 2/angiotensin-(1–7)/Mas axis activates Akt signaling to ameliorate hepatic steatosis
Cao, X., Yang, F., Shi, T., Yuan, M., Zhong, X., Xie, R.-R., Li, S., Li, H., & Yang, J. (2016) · Scientific Reports · doi:10.1038/srep21592 · Cited by 85
PPARγ is essential for protection against nonalcoholic steatohepatitis
Wu, C. W., Chu, E. S., Lam, C. N. Y., Cheng, A. S. L., Lee, C., Wong, V. W., Sung, J. J. �., & Yu, J. Q. (2010) · Gene Therapy · doi:10.1038/gt.2010.41 · Cited by 85
Effects of a Lactobacillus paracasei B21060 based synbiotic on steatosis, insulin signaling and toll-like receptor expression in rats fed a high-fat diet
Raso, G. M., Simeoli, R., Iacono, A., Santoro, A. N., Amero, P., Paciello, O., Russo, R., D’Agostino, G., Costanzo, M. D., Canani, R. B., et al. (2013) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2013.09.006 · Cited by 83
Is Adiponectin Involved in the Pathogenesis of Nonalcoholic Steatohepatitis?
Vuppalanchi, R., Marri, S., Kolwankar, D., Considine, R. V., & Chalasani, N. (2005) · Journal of Clinical Gastroenterology · doi:10.1097/01.mcg.0000152747.79773.2f · Cited by 83
Adipose-specific disruption of signal transducer and activator of transcription 3 increases body weight and adiposity
Cernkovich, E. R., Deng, J., Bond, M. C., Combs, T. P., & Harp, J. B. (2008) · Endocrinology · doi:10.1210/en.2007-1148 · Cited by 87
Therapy of nonalcoholic fatty liver disease: current status.
Duvnjak, M., Tomašić, V., Gomerčić, M., Duvnjak, L. S., Baršić, N., & Lerotić, I. (2009) · PubMed · Cited by 82
Mitochondrial dysfunction contributes to the increased vulnerabilities of adiponectin knockout mice to liver injury†
Zhou, M., Xu, A., Tam, P. K. H., Lam, K. S. L., Chan, L., Hoo, R. L. C., Liu, J., Chow, H., & Wang, Y. (2008) · Hepatology · doi:10.1002/hep.22444 · Cited by 86
Self-citation
Adiponectin and Leptin Concentrations May Aid in Discriminating Disease Forms in Children and Adolescents With Type 1 and Type 2 Diabetes
Morales, A. E., Wasserfall, C. H., Brusko, T. M., Carter, C., Schatz, D., Silverstein, J. H., Ellis, T., & Atkinson, M. A. (2004) · Diabetes Care · doi:10.2337/diacare.27.8.2010 · Cited by 82
An increase in liver PPARγ2 is an initial event to induce fatty liver in response to a diet high in butter: PPARγ2 knockdown improves fatty liver induced by high-saturated fat
Yamazaki, T., Shiraishi, S., Kishimoto, K., Miura, S., & Ezaki, O. (2010) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2010.04.009 · Cited by 81
Activation of peroxisome proliferator-activated receptor-γ by rosiglitazone improves lipid homeostasis at the adipose tissue-liver axis in ethanol-fed mice
Sun, X., Tang, Y., Tan, X., Li, Q., Zhong, W., Sun, X., Jia, W. P., McClain, C. J., & Zhou, Z. (2011) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00342.2011 · Cited by 81
The inhibitory effect of genistein on hepatic steatosis is linked to visceral adipocyte metabolism in mice with diet-induced non-alcoholic fatty liver disease
Kim, M., Kang, K., & Lee, Y.-S. (2010) · British Journal Of Nutrition · doi:10.1017/s0007114510002266 · Cited by 81
Non-alcoholic steatohepatitis
Jansen, P. L. M. (2004) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-200411000-00001 · Cited by 80
Dietary α-linolenic acid-rich flaxseed oil prevents against alcoholic hepatic steatosis via ameliorating lipid homeostasis at adipose tissue-liver axis in mice
Wang, M., Zhang, X., Feng, K., He, C., Li, P., Yuanjia, H., Su, H., & Wan, J. (2016) · Scientific Reports · doi:10.1038/srep26826 · Cited by 80
Nonalcoholic Fatty Liver Disease: Pathogenesis and Potential for Nuclear Receptors as Therapeutic Targets
George, J., & Liddle, C. (2007) · Molecular Pharmaceutics · doi:10.1021/mp700110z · Cited by 80
Induction of adiponectin in skeletal muscle of type 2 diabetic mice: In vivo and in vitro studies
Delaigle, A. M., Senou, M., Guiot, Y., Many, M. C., & Brichard, S. M. (2006) · Diabetologia · doi:10.1007/s00125-006-0210-y · Cited by 79
Obesity as the common soil of non‐alcoholic fatty liver disease and diabetes: Role of adipokines
Hui, E., Xu, A., Yang, H. B., & Lam, K. S. L. (2013) · Journal of Diabetes Investigation · doi:10.1111/jdi.12093 · Cited by 79
Self-citation

Authors: Xu, A., Wang, Y., Keshaw, H., Xu, L. Y., Lam, K. S. L., & Cooper, G. J. S.
Affiliations: University of Auckland (NZ)
University of Hong Kong (HK)
Corresponding author: Xu, Aimin
ORCID: Xu, Aimin
Wang, Yu
Lam, Karen S.L.
Cooper, Garth J.S.
Venue: Journal of Clinical Investigation
Publisher: American Society for Clinical Investigation
Published: 2003-07-01
Volume: 112
Issue: 1
Pages: 91-100
ISSN: 0021-9738 (ISSN-L)
DOI: 10.1172/jci200317797
PMC: PMC162288
OpenAlex: W2120590109
Cited by: 1,298
References: 68
Citations by year: 2026: 12 · 2025: 15 · 2024: 29 · 2023: 34 · 2022: 34 · 2021: 43 · 2020: 38 · 2019: 35 · 2018: 54 · 2017: 50 · 2016: 50 · 2015: 69 · 2014: 75 · 2013: 59 · 2012: 68
FWCI: 49.81
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: Journal of Clinical Investigation (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
The HKU Scholars Hub (University of Hong Kong) (submittedVersion)
Research Explorer (The University of Manchester) (submittedVersion)
Funders: Auckland Medical Research Foundation
University of Hong Kong
Health Research Council of New Zealand
Topics: Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
Health Sciences › Medicine › Pathology and Forensic Medicine › Alcohol Consumption and Health Effects
Keywords: adiponectin, alcoholic fatty liver, non-alcoholic fatty liver disease, hepatic steatosis, hepatomegaly, liver inflammation, TNF-α, carnitine palmitoyltransferase 1, hepatic fatty acid oxidation, fatty acid synthesis, acetyl-CoA carboxylase, fatty acid synthase, alanine aminotransferase, ob/ob mice, obesity
MeSH terms: Alanine Transaminase, Animals, Fatty Acids, Fatty Liver, Fatty Liver, Alcoholic, Liver, Male, Mice, Inbred C57BL, Obesity, Morbid, Oxidation-Reduction, Proteins, Recombinant Proteins, Tumor Necrosis Factor-alpha, Intercellular Signaling Peptides and Proteins, Mice, Adiponectin

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks